Markets:

Overview

News

Currencies

International

Treasuries

PharmaCyte Biotech, Inc. - Common Stock (NQ:PMCB)

0.9500 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PharmaCyte Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why Are PharmaCyte Shares Moving Higher On Thursday? ↗

September 16, 2021

PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate. These...

Via Benzinga

PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA

September 16, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

41 Stocks Moving In Friday's Mid-Day Session ↗

September 10, 2021

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...

Via Benzinga

60 Biggest Movers From Friday ↗

September 13, 2021

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...

Via Benzinga

Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday? ↗

September 09, 2021

The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today. Investors are expecting a major announcement from the company...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 09, 2021

Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff...

Via Benzinga

PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

September 08, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study

August 31, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise

August 25, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

60 Biggest Movers From Yesterday ↗

August 24, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...

Via Benzinga

PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

August 23, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

35 Stocks Moving In Monday's Mid-Day Session ↗

August 23, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...

Via Benzinga

25 Stocks Moving in Monday's Pre-Market Session ↗

August 23, 2021

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...

Via Benzinga

22 Stocks Moving in Friday's Pre-Market Session ↗

August 20, 2021

Gainers GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society...

Via Benzinga

58 Biggest Movers From Yesterday ↗

August 20, 2021

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 170 Points; DLocal Shares Spike Higher ↗

August 19, 2021

Toward the end of trading Thursday, the Dow traded down 0.49% to 34,790.15 while the NASDAQ fell 0.07% to 14,515.39. The S&P also fell, dropping 0.14% to 4,394.20. The U....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 19, 2021

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics'...

Via Benzinga

Mid-Day Market Update: Macy's Jumps After Q2 Results; PharmaCyte Biotech Shares Drop ↗

August 19, 2021

Midway through trading Thursday, the Dow traded down 0.40% to 34,819.43 while the NASDAQ rose 0.07% to 14,535.52. The S&P also fell, dropping 0.03% to 4,398.74. The U.S. has...

Via Benzinga

Topics Stocks

38 Stocks Moving In Thursday's Mid-Day Session ↗

August 19, 2021

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Flat; Estée Lauder Sales Top Views ↗

August 19, 2021

Following the market opening Thursday, the Dow traded down 0.06% to 34,940.82 while the NASDAQ rose 0.05% to 14,532.58. The S&P also rose, gaining 0.03% to 4,401.45. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 19, 2021

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 97.28% to $1.47 during Thursday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

PharmaCyte Biotech Announces $70 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

August 19, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

21 Stocks Moving in Thursday's Pre-Market Session ↗

August 19, 2021

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares rose 86.5% to $1.39 in pre-market trading after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...

Via Benzinga

46 Biggest Movers From Yesterday ↗

August 19, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 18, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX...

Via Benzinga

What's Up With PharmaCyte Biotech Shares Today? ↗

August 18, 2021

PharmaCyte Biotech Inc (NASDAQ: PMCB) is surging higher Wednesday on abnormally-high volume following the company's recent listing on the Nasdaq. PharmaCyte Biotech ...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 18, 2021

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading volume for PharmaCyte Biotech's stock is 144.3...

Via Benzinga

34 Stocks Moving In Wednesday's Mid-Day Session ↗

August 18, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Target Reports Upbeat Profit ↗

August 18, 2021

Following the market opening Wednesday, the Dow traded down 0.12% to 35,300.85 while the NASDAQ rose 0.03% to 14,660.26. The S&P also fell, dropping 0.04% to 4,446.09. The U.S...

Via Benzinga

Topics Stocks

PMCB Stock: 14 Things to Know About PharmaCyte Biotech as Shares Skyrocket ↗

August 18, 2021

PharmaCyte Biotech (PMCB) stock is taking off Wednesday and there are a few things that potential investors need to know about the company.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

PharmaCyte Biotech, Inc. - Common Stock (NQ:PMCB)

All News about PharmaCyte Biotech, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today